Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of receivables with imputed interest (Details)

v3.25.1
Schedule of receivables with imputed interest (Details) - USD ($)
Dec. 31, 2024
Jun. 11, 2024
Dec. 31, 2023
Receivables [Abstract]      
Face value $ 287,200 [1] $ 287,200 $ 285,400 [1]
Impairment (250,208) 250,208
Total 36,992   285,400
Unamortized discount (36,992) $ 36,992 (46,551)
Net balance   238,849
Long term portion   $ 238,849
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.